Cargando…

RNA Vaccination Therapy: Advances in an Emerging Field

Detalles Bibliográficos
Autores principales:	Kreiter, Sebastian, Diken, Mustafa, Pascolo, Steve, Nair, Smita K., Thielemans, Kris M., Geall, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785387/ https://www.ncbi.nlm.nih.gov/pubmed/27019856 http://dx.doi.org/10.1155/2016/9703914

Ejemplares similares

CIMT 2013: Advancing targeted therapies—report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14–16 2013, Mainz, Germany
por: Diken, Mustafa, et al.
Publicado: (2013)

HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory
por: Grunwitz, Christian, et al.
Publicado: (2019)

A liposomal RNA vaccine inducing neoantigen-specific CD4(+) T cells augments the antitumor activity of local radiotherapy in mice
por: Salomon, Nadja, et al.
Publicado: (2020)

Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16(+) cancer
por: Salomon, Nadja, et al.
Publicado: (2021)

Synthetic Messenger RNA-Based Vaccines: From Scorn to Hype
por: Pascolo, Steve
Publicado: (2021)

An Update on Self-Amplifying mRNA Vaccine Development
por: Blakney, Anna K., et al.
Publicado: (2021)

Vaccines against COVID-19: Priority to mRNA-Based Formulations
por: Pascolo, Steve
Publicado: (2021)

Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion Proteins
por: Beissert, Tim, et al.
Publicado: (2017)

mRNA Innovates the Vaccine Field
por: Pardi, Norbert
Publicado: (2021)

Next generation self-replicating RNA vectors for vaccines and immunotherapies
por: Aliahmad, Parinaz, et al.
Publicado: (2022)

Neo-Antigen mRNA Vaccines
por: Esprit, Arthur, et al.
Publicado: (2020)

CIMT 2014: Next waves in cancer immunotherapy - Report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany
por: Diken, Mustafa, et al.
Publicado: (2014)

Targeting the tumor mutanome for personalized vaccination therapy
por: Kreiter, Sebastian, et al.
Publicado: (2012)

CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy
por: Kranz, Lena M, et al.
Publicado: (2015)

Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients
por: Romano, Emanuela, et al.
Publicado: (2021)

Dexamethasone premedication suppresses vaccine-induced immune responses against cancer
por: Vormehr, Mathias, et al.
Publicado: (2020)

Overcoming HLA restriction in clinical trials: Immune monitoring of mRNA-loaded DC therapy
por: Van Nuffel, An M.T., et al.
Publicado: (2012)

RNA with chemotherapeutic base analogues as a dual-functional anti-cancer drug
por: Jarzebska, Natalia Teresa, et al.
Publicado: (2022)

Molecular therapies and vaccines face the challenges of emerging infectious diseases
por: Patel, Ami, et al.
Publicado: (2022)

Advancement of the Emerging Field of RNA Nanotechnology
por: Jasinski, Daniel, et al.
Publicado: (2017)

CEC01-02 Development of mRNA-based vaccines
por: Pascolo, S.
Publicado: (2022)

TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
por: De Keersmaecker, Brenda, et al.
Publicado: (2020)

CIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany
por: Kranz, Lena M., et al.
Publicado: (2016)

Phase II study of autologous mRNA electroporated dendritic cells (TriMixDC-MEL) in combination with Ipilimumab in patients with pretreated advanced melanoma
por: Thielemans, Kris, et al.
Publicado: (2014)

Mutated tumor alleles are expressed according to their DNA frequency
por: Castle, John C., et al.
Publicado: (2014)

Vaccine and Vaccination: On Field Research
por: Gallè, Francesca, et al.
Publicado: (2022)

The Emerging Field of Nutritional Dentistry
por: Woelber, Johan Peter, et al.
Publicado: (2022)

Recent Updates on mRNA Vaccines
por: Sydow, Emily, et al.
Publicado: (2022)

Advanced Field-Effect Sensors
por: Di Bartolomeo, Antonio
Publicado: (2023)

Vaccine Effectiveness Studies in the Field
por: Evans, Stephen J.W., et al.
Publicado: (2021)

Editorial: an emerging field with bright prospects
por: Corr, Philip, et al.
Publicado: (2023)

Value-based pricing for advanced therapy medicinal products: emerging affordability solutions
por: Gonçalves, Elisabete
Publicado: (2021)

Delivery Systems of Plasmid DNA and Messenger RNA for Advanced Therapies
por: Uchida, Satoshi
Publicado: (2022)

Public health and emergency workforce: a roadmap for WHO and partner contributions
por: Mosam, Atiya, et al.
Publicado: (2022)

Recent Advances and Trends in the Dairy Field
por: Saldo, Jordi, et al.
Publicado: (2022)

mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic
por: Van Lint, Sandra, et al.
Publicado: (2013)

Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ
por: Cu, Yen, et al.
Publicado: (2013)

Advances in Emerging Solar Cells
por: Batmunkh, Munkhbayar
Publicado: (2020)

RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune System
por: De Mey, Wout, et al.
Publicado: (2022)

Advances in Vaccine Development
por: Tripp, Ralph A.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q7u0pr17nmt94q10203kr4h8qm